ATP2A1-ATXN2L Fusion FISH Probe
The ATP2A1-ATXN2L Fusion FISH Probe is used to confirm a fusion of the ATP2A1 and ATXN2L genes. The fusion of the ATP2A1 and ATXN2L genes has been associated with Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ATP2A1-ATXN2L-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ATP2A1-ATXN2L-20-AQAQ | 20 (40 μL) | 200 μL |
|
ATP2A1 Gene Summary
This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in muscular excitation and contraction. Mutations in this gene cause some autosomal recessive forms of Brody disease, characterized by increasing impairment of muscular relaxation during exercise. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Oct 2013]
Gene Name: ATPase Sarcoplasmic/endoplasmic Reticulum Ca2+ Transporting 1
Chromosome: CHR16: 28889808 -28915830
Locus: 16p11.2
ATXN2L Gene Summary
This gene encodes an ataxin type 2 related protein of unknown function. This protein is a member of the spinocerebellar ataxia (SCAs) family, which is associated with a complex group of neurodegenerative disorders. Several alternatively spliced transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Ataxin 2 Like
Chromosome: CHR16: 28834413 -28848558
Locus: 16p11.2
Gene Diseases
The ATP2A1 ATXN2L Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|